Telix Pharmaceuticals Ltd banner

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 11.29 AUD 0.53% Market Closed
Market Cap: AU$3.8B

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 24.31 AUD with a low forecast of 17.17 AUD and a high forecast of 35.7 AUD.

Lowest
Price Target
17.17 AUD
52% Upside
Average
Price Target
24.31 AUD
115% Upside
Highest
Price Target
35.7 AUD
216% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
ANY
ANY Biztonsagi Nyomda Nyrt
-4% Downside
RCKT
Rocket Pharmaceuticals Inc
66% Upside
WASH
Washington Trust Bancorp Inc
11% Upside

Revenue
Forecast

228% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
228% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 7 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 228%. The projected CAGR for the next 3 years is 17%.

Operating Income
Forecast

N/A
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat
N/A
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 72%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
24.31 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 24.31 AUD with a low forecast of 17.17 AUD and a high forecast of 35.7 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
17%

For the last 7 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 228%. The projected CAGR for the next 3 years is 17%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
72%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 72%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett